Genetic Testing Cost Effective for Newly Diagnosed GIST
Health & BehaviorUC San Diego School of Medicine researchers reported that genetic testing is cost-effective and beneficial for newly diagnosed patients with metastatic gastrointestinal stromal tumors (GIST), a rare type of cancer.